For the quarter ending 2025-09-30, UEEC had $18,151 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) | -285,594 | -1,846,846 |
| Stock for services and compensation | 0 | 1,120,125 |
| Write-off inventory | 0 | 0 |
| Amortization expense | 1,012 | 2,025 |
| Amortization of right-of-use asset | -350 | -110 |
| Gain on settlement of debt | 0 | - |
| Prepaid and other current assets | 3,867 | -1,914 |
| Accounts payable and accrued expenses | 112,382 | 125,534 |
| Accrued liabilities - related party | 21,731 | 43,462 |
| Accrued compensation | -20,471 | 95,238 |
| Net cash used in operating activities | -175,157 | -458,658 |
| Net cash used in investing activities | 0 | 0 |
| Proceeds from convertible notes payable | 130,000 | 290,000 |
| Advance from related party | 0 | 20,000 |
| Repayment of advance from related party | 0 | 20,000 |
| Payment of offering costs | 2,400 | 0 |
| Proceeds from note payable | 0 | - |
| Proceeds from sale of common stock | 65,708 | 0 |
| Net cash provided by financing activities | 193,308 | 290,000 |
| Increase (decrease) in cash and cash equivalents | 18,151 | -168,658 |
| Cash and cash equivalents at beginning of period | 168,883 | - |
| Cash and cash equivalents at end of period | 18,376 | - |
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)